What have we learnt from the rosiglitazone saga?

Victor M. Montori; Nilay D. Shah

doi:10.1136/bmj.d1354

What have we learnt from the rosiglitazone saga?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	d1354
Pages (from-to)	666
Number of pages	1
Journal	BMJ
Volume	342
Issue number	7799
DOIs	https://doi.org/10.1136/bmj.d1354
State	Published - Mar 26 2011

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/bmj.d1354

Cite this

@article{e54eb2fee22f49aca9be0f4c62988fa4,

title = "What have we learnt from the rosiglitazone saga?",

author = "Montori, {Victor M.} and Shah, {Nilay D.}",

year = "2011",

month = mar,

day = "26",

doi = "10.1136/bmj.d1354",

language = "English (US)",

volume = "342",

pages = "666",

journal = "BMJ",

issn = "0959-8146",